Axoft
Revolutionary soft brain-computer interfaces
About
Founded around 2020, Axoft is a neurotechnology startup pioneering soft brain-computer interfaces. Their core product enables non-invasive neural communication to advance brain-computer interaction with applications in clinical trials and global health markets. The business model revolves around scaling their technology through clinical validation, prototype scaling, and commercialization, supported by significant Series A funding. Axoft leverages advanced materials and neurotech innovation to target healthcare and life sciences sectors internationally.
Products
- Soft Brain-Computer Interface
- Fleuron Neuro-Material Formulations
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Axoft — available to members.
